Nanotechnology, Antibiotics, and Monkeys?
At the end of April the United States Food and Drug Administration announced it was approving an antibiotic to treat patients with the plague, a very rare bacterial infection, most commonly presenting as cases of bubonic plague (infection of the lymph nodes), pneumonic plague (infection of the lungs), or septicemic plague (infection of the blood). Cases of the plague are very rare anywhere in the world (1000-2000 annually) but the approval highlights the global view on antibiotics in light of emerging and remerging infectious disease. Read further >

